SP101, a novel synthetic compound reduces the drug resistance of EGFR(T790M) and cancerous stemness in non-small cell lung carcinoma

Full metadata record

DC Field	Value	Language
dc.contributor.author	Chao, Jui-I	en_US
dc.date.accessioned	2018-08-21T05:54:21Z	-
dc.date.available	2018-08-21T05:54:21Z	-
dc.date.issued	2016-04-01	en_US
dc.identifier.issn	0892-6638	en_US
dc.identifier.uri	http://hdl.handle.net/11536/145847	-
dc.language.iso	en_US	en_US
dc.title	SP101, a novel synthetic compound reduces the drug resistance of EGFR(T790M) and cancerous stemness in non-small cell lung carcinoma	en_US
dc.type	Article	en_US
dc.identifier.journal	FASEB JOURNAL	en_US
dc.citation.volume	30	en_US
dc.citation.issue	1	en_US
dc.contributor.department	生物科技學系	zh_TW
dc.contributor.department	分子醫學與生物工程研究所	zh_TW
dc.contributor.department	Department of Biological Science and Technology	en_US
dc.contributor.department	Institute of Molecular Medicine and Bioengineering	en_US
dc.identifier.wosnumber	WOS:000406444004424	en_US
Appears in Collections:	Articles